Schaper Benz & Wise Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Hold
316
0.03% 141
2026
Q1
$291K Buy
316
+4
+1% +$4.05K 0.02% 142
2025
Q4
$335K Buy
+312
New +$298K 0.02% 139
2025
Q1
Sell
-407
Closed -$314K 150
2024
Q4
$314K Sell
407
-143
-26% -$118K 0.03% 131
2024
Q3
$487K Buy
550
+143
+35% +$129K 0.04% 116
2024
Q2
$368K Sell
407
-10
-2% -$8K 0.03% 120
2024
Q1
$324K Buy
+417
New +$297K 0.03% 125

Other funds holding LLY

Schaper Benz & Wise Investment Counsel's LLY Position: Q2 2026 in Review

Schaper Benz & Wise Investment Counsel held its Eli Lilly (LLY) position steady in Q2 2026 at 316 shares worth $379K. The position accounts for 0.03% of the portfolio, ranked #141.

Schaper Benz & Wise Investment Counsel first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. The position peaked at $487K in Q3 2024. 1,763 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Schaper Benz & Wise Investment Counsel held 316 shares of Eli Lilly worth $379K as of Q2 2026.
  • Schaper Benz & Wise Investment Counsel left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.03% of Schaper Benz & Wise Investment Counsel's portfolio in Q2 2026, its #141 holding.
  • Schaper Benz & Wise Investment Counsel first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
  • Schaper Benz & Wise Investment Counsel's Eli Lilly position peaked at $487K in Q3 2024.
  • 1,763 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2026, filed 21 Jul 2026.